Economic value, affordability, and scale-up of adjuvant immunotherapies in lung cancer treatment: From cost-effectiveness decision to budget impact analysis
Authors
Padam Kanta Dahal (ORCID: https://orcid.org/0000-0002-5978-3762)
Economic value, affordability, and scale-up of adjuvant immunotherapies in lung cancer treatment: From cost-effectiveness decision to budget impact analysis
Padam Kanta Dahal, Nasrin Akter, Rashidul Alam Mahumud, Khorshed Alam et al.
Journal
Journal of Cancer Policy
Topics
Economic and Financial Impacts of Cancer
article
Economic value, affordability, and scale-up of adjuvant immunotherapies in lung cancer treatment: From cost-effectiveness decision to budget impact analysis
Padam Kanta Dahal, Nasrin Akter, Rashidul Alam Mahumud, Khorshed Alam, Yifu Chen, Md Shahjalal
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Cancer PolicyVol. 47
Institutions
The University of Sydney (AU), North South University (BD), University of Southern Queensland (AU), Central Queensland University (AU), Northern University Bangladesh (BD)